William Hornebeck Selected Research

William Hornebeck Research Topics

Disease

16	Neoplasms (Cancer) 06/2009 - 06/2002
9	Melanoma (Melanoma, Malignant) 06/2009 - 06/2002
2	Fibrosarcoma 02/2008 - 01/2002
2	Necrosis 07/2007 - 05/2002
2	Pathologic Processes 06/2003 - 01/2003
1	Atherosclerosis 08/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2012
1	Lung Neoplasms (Lung Cancer) 07/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2012
1	Wounds and Injuries (Trauma) 09/2009
1	Reperfusion Injury 07/2007
1	Ischemia 07/2007
1	Colorectal Neoplasms (Colorectal Cancer) 01/2007
1	Microsatellite Instability 01/2007
1	Erythema 12/2005
1	Virus Diseases (Viral Diseases) 03/2005
1	Osteosarcoma (Osteogenic Sarcoma) 03/2005
1	Vascular Diseases (Vascular Disease) 02/2004

Drug/Important Bio-Agent (IBA)

13	Matrix Metalloproteinases (MMPs)IBA 01/2007 - 01/2002
9	ElastinIBA 08/2013 - 01/2002
8	Peptides (Polypeptides)IBA 09/2009 - 01/2002
7	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2009 - 11/2003
5	cyclohexenoesculetin-beta-galactoside (S-Gal)IBA 07/2007 - 06/2002
5	Metalloproteases (Metalloproteinases)IBA 01/2007 - 06/2003
5	Peptide Hydrolases (Proteases)FDA Link 12/2004 - 06/2002
4	elastin-binding proteinsIBA 09/2009 - 01/2002
4	CytokinesIBA 11/2007 - 11/2003
4	Collagen Type I (Type I Collagen)IBA 07/2005 - 01/2002
3	CollagenIBA 06/2009 - 03/2004
3	collagenase 1IBA 06/2009 - 07/2003
3	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2007 - 06/2002
3	Fibrinolysin FDA Link 02/2004 - 01/2003
2	Pancreatic Elastase (Elastase)IBA 08/2013 - 09/2009
2	ThrombospondinsIBA 02/2008 - 12/2004
2	EnzymesIBA 02/2008 - 07/2003
2	Tissue Inhibitor of Metalloproteinase-2IBA 01/2007 - 11/2003
2	Tissue Inhibitor of Metalloproteinase-1IBA 01/2007 - 03/2005
2	Proteins (Proteins, Gene)FDA Link 12/2004 - 05/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2004 - 11/2003
2	PlasminogenIBA 11/2003 - 01/2002
1	Leukocyte Elastase (Neutrophil Elastase)IBA 07/2012
1	Collagenases (Collagenase)FDA Link 06/2009
1	N-acetylsphingosineIBA 10/2008
1	Histones (Histone)IBA 10/2008
1	CeramidesIBA 10/2008
1	trichostatin A (A 300)IBA 10/2008
1	Histone Deacetylase InhibitorsIBA 10/2008
1	Thrombospondin 1IBA 02/2008
1	Creatine Kinase (Creatine Phosphokinase)IBA 07/2007
1	Phosphotransferases (Kinase)IBA 07/2007
1	GelatinasesIBA 01/2007
1	Transcription Factors (Transcription Factor)IBA 12/2005
1	DisintegrinsIBA 03/2005
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 03/2005
1	LDL Receptors (LDL Receptor)IBA 12/2004
1	EndopeptidasesIBA 03/2004
1	ZincIBA 03/2004
1	Matrix Metalloproteinase InhibitorsIBA 03/2004
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2004
1	Lactose FDA LinkGeneric 02/2004
1	beta-Galactosidase (Lactaid)IBA 02/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2003
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 07/2003
1	estropipate (Ogen)FDA LinkGeneric 01/2003
1	Integrin alphaVbeta3IBA 06/2002
1	Collagen Type IV (Type IV Collagen)IBA 06/2002
1	progelatinaseIBA 06/2002
1	valyl-glycyl-valyl-alanyl-prolyl-glycineIBA 06/2002
1	Messenger RNA (mRNA)IBA 05/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2002
1	Interleukin-8 (Interleukin 8)IBA 05/2002
1	InterleukinsIBA 05/2002

Therapy/Procedure

1	Therapeutics 03/2005
1	Subcutaneous Injections 11/2003